Clinical Trial Update: Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial evaluating chemotherapy in combination with cetuximab for patients with liver metastases from colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED